Markedly prolonged theophylline half-life in liver failure

Area of Science:

• Pharmacology
• Hepatology
• Clinical Toxicology

Background:

• Theophylline is a medication commonly used for respiratory conditions.
• Hepatic impairment can significantly alter drug metabolism and clearance.
• Accurate monitoring of drug levels is essential for patient safety.

Observation:

• A 63-year-old male with a history of alcoholism and likely cirrhosis presented with symptoms of theophylline toxicity.
• Following drug discontinuation, the patient exhibited an exceptionally prolonged serum theophylline half-life of 134 hours.
• This clinical presentation suggests severely impaired theophylline clearance due to hepatic dysfunction.

Findings:

• Hepatic disease markedly reduces theophylline clearance.
• Elevated serum theophylline concentrations can lead to toxicity even with standard dosing.
• Prolonged drug half-life indicates a critical need for dose adjustment and vigilant monitoring.

Implications:

• Cirrhotic patients require individualized theophylline dosing strategies.
• Frequent therapeutic drug monitoring of plasma theophylline concentrations is vital in patients with liver disease.
• This case highlights the potential for severe drug toxicity in the presence of hepatic impairment, necessitating careful clinical management.